MDM2 p.Arg71Gln
c.212G>A · rs1385829631 · VCV1501438
Computational evidence
| Protein change | ||
| AlphaMissense | 0.0776 | likely benign |
|---|---|---|
| REVEL | 0.108 | moderately benign-leaning |
| SaProt | LLR -5.61 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | <0.2 | all four deltas below 0.2 · G>T here scores Δ0.26 · evaluated, not missing |
| Constraint at this position | ||
| Conservation | phyloP 6.6 | GERP 1.9, phastCons 1 |
| Regional constraint | o/e 0.27 | constrained · MANE · 6,789 bp · p 9.7e-12 · regional, not allelic |
| Overall | ||
| CADD | 21.2 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
⚠ Isoform check: AlphaMissense numbered on a different transcript (AM R65Q vs ClinVar R71Q) — verify the residue.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Remaining individualsnot grpmax-eligible | 0.00321% | 31,150 |
| East Asiangrpmax | 0.00224% | 44,668 |
Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- MDM2
- Protein
- p.Arg71Gln
- Coding
- c.212G>A
- MANE Select
- NM_002392
- dbSNP
- rs1385829631
- Type
- single nucleotide variant
- Location
- chr12:68816849 (GRCh38)
- Gene constraint
- LOEUF 0.325 · pLI 1.00 (gnomAD)
- Structure
- AlphaFold pLDDT 63.24 · 148 PDB
- Residue 71
- the swib/mdm2 domain; the 'necessary for interaction with usp2' region; the 'sufficient to promote the mitochondrial pathway of apoptosis' region; a β-strand
Similar variants
- MDM2 c.523+5A>G Uncertain significance ★★ same condition
- MDM2 p.Arg332His Uncertain significance ★★ ⚠ same condition
- MDM2 p.Asn117Ser Uncertain significance ★★ ⚠ same condition
- MDM2 p.Asn374Ser Uncertain significance ★★ ⚠ same condition
- MDM2 p.Gln414Leu Uncertain significance ★★ ⚠ same condition
- MDM2 p.Glu273Ala Uncertain significance ★★ ⚠ same condition
- MDM2 p.Gly341Glu Uncertain significance ★★ ⚠ same condition
- MDM2 p.Ser122Leu Uncertain significance ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/mdm2-p-arg71gln (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown